Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceuti...
Japan-based startup Elix, Inc., an artificial intelligenet (AI) drug discovery company with the mission of “Rethin...
GlaxoSmithKline (GSK) Singapore has announced that Health Sciences Authority has approved Zejula&nbs...
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...
South Korean startup ILIAS Biologics has signed a Memorandum of Understanding (MoU) with HK inno.N for joint research to...
Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Merck Kore...
Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...
Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...
Japan-based Fujitsu and RIKEN have launched a joint research project on next-generation IT drug discovery technology uti...
The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaboration for co-...
Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...
TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...
Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...
RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...
Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...
